1. Home
  2. NKTR vs NNBR Comparison

NKTR vs NNBR Comparison

Compare NKTR & NNBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • NNBR
  • Stock Information
  • Founded
  • NKTR 1990
  • NNBR 1980
  • Country
  • NKTR United States
  • NNBR United States
  • Employees
  • NKTR N/A
  • NNBR N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • NNBR Industrial Machinery/Components
  • Sector
  • NKTR Health Care
  • NNBR Industrials
  • Exchange
  • NKTR Nasdaq
  • NNBR Nasdaq
  • Market Cap
  • NKTR 160.4M
  • NNBR 149.8M
  • IPO Year
  • NKTR 1994
  • NNBR 1994
  • Fundamental
  • Price
  • NKTR $0.74
  • NNBR $2.45
  • Analyst Decision
  • NKTR Strong Buy
  • NNBR
  • Analyst Count
  • NKTR 5
  • NNBR 0
  • Target Price
  • NKTR $5.50
  • NNBR N/A
  • AVG Volume (30 Days)
  • NKTR 1.4M
  • NNBR 158.6K
  • Earning Date
  • NKTR 03-12-2025
  • NNBR 03-05-2025
  • Dividend Yield
  • NKTR N/A
  • NNBR N/A
  • EPS Growth
  • NKTR N/A
  • NNBR N/A
  • EPS
  • NKTR N/A
  • NNBR N/A
  • Revenue
  • NKTR $98,427,000.00
  • NNBR $464,290,000.00
  • Revenue This Year
  • NKTR N/A
  • NNBR $3.17
  • Revenue Next Year
  • NKTR N/A
  • NNBR $5.90
  • P/E Ratio
  • NKTR N/A
  • NNBR N/A
  • Revenue Growth
  • NKTR 9.21
  • NNBR N/A
  • 52 Week Low
  • NKTR $0.65
  • NNBR $2.38
  • 52 Week High
  • NKTR $1.93
  • NNBR $4.86
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 36.32
  • NNBR 37.47
  • Support Level
  • NKTR $0.84
  • NNBR $2.38
  • Resistance Level
  • NKTR $0.92
  • NNBR $2.67
  • Average True Range (ATR)
  • NKTR 0.08
  • NNBR 0.14
  • MACD
  • NKTR -0.01
  • NNBR 0.00
  • Stochastic Oscillator
  • NKTR 0.40
  • NNBR 19.71

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About NNBR NN Inc.

NN Inc is a diversified industrial company that combines engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision solutions and components. It operates in two business segments: mobile solutions and power solutions. The mobile solutions segment involves growth in the general industrial and automotive end markets. Its power solutions segment involves growth in the electrical and aerospace and defense end markets. It also operates in China, Mexico, Brazil, Germany, and other countries.

Share on Social Networks: